Bill Ackman on Valeant Bid for Allergan; Herbalife

July 21 (Bloomberg) -- Bill Ackman, chief executive officer Pershing Square Capital Management LP, talks about Valeant Pharmaceuticals International Inc.'s hostile takeover bid for Allergan Inc. Ackman, speaking with Erik Schatzker and Stephanie Rule on Bloomberg Television's "Bottom Line," also discusses the outlook for his company's probe into the business model of Herbalife Ltd. (Source: Bloomberg)

Soylent: The Food of the Future?
35:00 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Full Show: What'd You Miss? (07/22)
  • Should More Filmmakers Use Virtual Reality Technology?
  • How Important Is the Smartwatch Market to Apple?